Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 12.05.2025
Salzgitter Aktiengesellschaft
Result includes around € 23 million in charges from the reporting-date-related valuation of derivative positions and € 10 million in impairment risk from planned portfolio streamlining
€ 78.6 million in earnings before interest, taxes, depreciation and amortization (EBITDA)
P28 performance program generates an additional € 14 million contribution [ … ]
Mon, 12.05.2025
Hypoport SE
Group Results Q1/2025
Hypoport starts 2025 with strong earnings in Q1
• Group revenue increases by 19% year-on-year to €159 million in Q1/2025
• Gross profit expands by 15% year-on-year to €66 million
• EBIT rises disproportionately by 88% to €8.6 million
• Recovery of business models in private real estate financing continues
Berli [ … ]
Mon, 12.05.2025
All for One Group SE
Solid growth in the cloud // Pinnacle Award 2025 // Geopolitical environment leads to project delays despite strong pipeline // Forecast confirmed
Unaudited results:
Sales rise only slightly to EUR 257.6 million due to move to the cloud (prior year: EUR 256.6 million)
Solid growth in cloud services up 5%
Geopolitical uncertainties lead to proje [ … ]
Mon, 12.05.2025
AEVIS VICTORIA SA
Ad hoc announcement pursuant to Art. 53 LR
Fribourg, 12 May 2025
AEVIS VICTORIA SA (AEVS.SW) – Sustained revenue growth in operating divisions. An increase of 17.0% was recorded in the first quarter of 2025.
AEVIS VICTORIA SA (AEVIS) recorded consolidated revenues of CHF 329.7 million in the first quarter of 2025 (Q1 2024: CHF 281.9 million), m [ … ]
Mon, 12.05.2025
Newron Pharmaceuticals S.p.A.
Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; enrollment to start imminently; 12-week study results expected in Q4 202 [ … ]
Mon, 12.05.2025
ProCredit Holding AG
ProCredit in Q1 advances on its growth and transformation strategy with good financial result
Loan growth of EUR 174 million or 2.5%; good growth in all client segments and across South Eastern and Eastern Europe
Group result of EUR 25.2 million corresponds to RoE of 9.5%
Cost-income ratio at 70.8%; strategic investments in growth catalysts begi [ … ]
Mon, 12.05.2025
Formycon AG
Press Release // May 12, 2025
Formycon reports strong operational performance and financial results for first quarter of 2025
Strong operational start to the year with market approvals for FYB203 (Aflibercept) in Europe and the United Kingdom as well as new commercialization partnerships with Teva and Lotus
Encouraging market launch of FYB202/Ot [ … ]
Sat, 10.05.2025
InvestHK
EQS Newswire / 10/05/2025 / 12:00 CET/CEST
HONG KONG SAR - Media OutReach Newswire - 10 May 2025 - Invest Hong Kong (InvestHK) announced today (May 10) that the Director-General of Investment Promotion at InvestHK, Ms Alpha Lau, will embark on a series of visits to Istanbul, Türkiye; Budapest, Hungary; and Cairo, Egypt, some of the key economi [ … ]
Fri, 09.05.2025
Mynaric AG
MUNICH, May 9, 2025 – Mynaric AG (OTC: MYNAY, MOYFF; ISIN: US62857X1019) (FRA: M0YN; ISIN: DE000A31C305) (the “Company”) announces the early disbursement of up to USD 10.5 million from the already agreed USD 25 million restructuring facility by its existing lenders due to delays in StaRUG proceedings.
On February 7, 2025, the Company had announced [ … ]
Fri, 09.05.2025
IuteCredit Finance S.à r.l.
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE U [ … ]